Andy Hyland

Scientific Principal Investigator, NIH/FDA PATH Study

Roswell Park Comprehensive Cancer Center


Andrew Hyland is the Chair of the Department of Health Behavior at Roswell Park Comprehensive Cancer Center and the Scientific Principal Investigator of the Population Assessment of Tobacco and Health (PATH) study, which is supported by the National Institute on Drug Abuse and the Food and Drug Administration to study more than 46,000 adults and children nationally over a 14 year period to understand changes in tobacco use behaviors and health. Dr. Hyland’s research program is focused on providing an evidence base to inform policies, regulations, and interventions to reduce the disease burden caused by tobacco by as much and to as many people as quickly as possible.  He has conducted numerous funded clinical and population-based studies, published more than 270 papers, and has been recognized for his service and scholarship by both local and international agencies.

« Back